13.97
-0.64%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Yantai Zhenghai Bio-Tech Co
Its shares trade on Shenzhen under the ticker 300653.SZ. It has been listed since 16 May 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥364.1m and net income of CN¥82.4m. At that date it held total assets of CN¥984.6m and shareholders' equity of CN¥889.5m.
Yantai Zhenghai Bio-Tech Co., Ltd. engages in the research & development, production, and sale of regenerative medicine related products such as soft tissue, and hard tissue repair materials. The company is headquartered in Yantai, Shandong. The company went IPO on 2017-05-16. The firm has two types of products which are soft tissue repair materials and hard tissue repair materials. The soft tissue repair materials include oral repair membranes, biofilms and skin repair membranes. The hard tissue repair materials include bone repair materials.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 16 May 2017
- Employees
- 376
- Website
- zhbio.com ↗
Leadership
Pay as last reported
- Mr. Huanxiang GuoChairman of the Board, since 2024
- Ms. Li ZhaoChief Financial Officer, Finance Director, Deputy General Manager, Secretary of the Board, Director, since 2015
- Mr. Kan SongGeneral Manager, Director, since 2022
- Mr. Donggang ZhangDeputy General Manager, Staff Elected Director, since 2017
- Mr. Xing YangDeputy General Manager
- Ms. Yueli XuDirector
- Mr. Chao ZhangDirector
- Mr. Jianghua LiIndependent Director
- Mr. Xiliang SongIndependent Director
- Mr. Hui WangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Yantai Zhenghai Bio-Tech employs 376 full-time employees in biotechnology research and development.
- The company produces soft tissue repair membranes and skin repair membranes for medical use.
- Yantai Zhenghai Bio-Tech specializes in regenerative medicine with two product types: soft and hard tissue repair materials.
Weaknesses
- The company has only two product types: soft tissue and hard tissue repair materials.
- Yantai Zhenghai Bio-Tech has no mention of international markets or global expansion plans.
- The firm's business is limited to regenerative medicine within the Health Care sector.
Opportunities
- The growing demand for regenerative medicine in China's Health Care sector presents opportunities.
- Yantai Zhenghai Bio-Tech could expand into new markets within the Health Care industry.
- Increasing focus on biotechnology in Shandong province offers potential growth areas.
Threats
- The company faces competition from other biotechnology firms in the Health Care sector.
- Regulatory changes in China's Health Care industry could impact product approvals.
- Dependence on a single sector (Health Care) may limit growth opportunities.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.